Cadent Therapeutics

Biopharmaceutical company developing small-molecule therapeutics for nervous system and neuropsychiatric disorders, including spinocerebellar ataxia and schizophrenia

Biotech & Life Sciences

Sector

Biotechnology drug discovery and development

Model

01Company Overview

Biopharmaceutical company developing small-molecule therapeutics for nervous system and neuropsychiatric disorders, including spinocerebellar ataxia and schizophrenia. Its clinical programs included CAD-1883 and CAD-9303.

02Backed By1 investor

AVAtlas Venture→

03Similar Companies

Is this your company? Claim your profile